Skip to main navigation Skip to search Skip to main content

Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: Clinical results of the PG21 study of 0.4 µg daily microdose

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: Clinical results of the PG21 study of 0.4 µg daily microdose'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases